Invesco’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$88.4K Buy
19,647
+1,246
+7% +$4.98K ﹤0.01% 3637
2025
Q4
$70.1K Buy
18,401
+644
+4% +$2.5K ﹤0.01% 3673
2025
Q3
$57.4K Buy
17,757
+2,553
+17% +$9.57K ﹤0.01% 3740
2025
Q2
$43.9K Sell
15,204
-908
-6% -$2.1K ﹤0.01% 3731
2025
Q1
$34.6K Sell
16,112
-148
-0.9% -$468 ﹤0.01% 3721
2024
Q4
$62.9K Buy
16,260
+2,793
+21% +$18.4K ﹤0.01% 3670
2024
Q3
$88.2K Sell
13,467
-427,820
-97% -$3.44M ﹤0.01% 3632
2024
Q2
$3.2M Buy
441,287
+429,471
+3,635% +$3.29M ﹤0.01% 2389
2024
Q1
$89.7K Sell
11,816
-442
-4% -$3.44K ﹤0.01% 3758
2023
Q4
$55.8K Buy
+12,258
New +$41.4K ﹤0.01% 3743
2019
Q1
Sell
-1,282
Closed -$76K 3768
2018
Q4
$76K Buy
+1,282
New +$127K ﹤0.01% 3673
2016
Q1
Sell
-3,220
Closed -$243K 3732
2015
Q4
$243K Buy
3,220
+47
+1% +$7.55K ﹤0.01% 3522
2015
Q3
$1.22M Buy
3,173
+3,161
+26,342% +$1.43M ﹤0.01% 2808
2015
Q2
$5K Buy
+12
New +$5.02K ﹤0.01% 4205

Other funds holding LRMR